MMP9 and renal pelvis/ureter urothelial carcinoma: Our study, the first to assess MMP-2 and MMP-9 genotypes’ impact on UTUC risk, highlighted the differential distribution of MMP-2 rs2285053 and MMP-9 rs3918242 genotypes between UTUC and control groups (in Table 2).